Search Results

FILTER BY

1 - 12 of 48 matches

Sort by:

NewsConference NewsAHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

November 11, 2023

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

January 10, 2022

Partner Content

Registration: Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty& Chordal Repair

December 15, 2021

Partner Content

Registration: Tricuspid Valve Therapies: Why a Transcatheter Toolbox is Required?

August 30, 2021

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 6, 2020

NewsOpinionCV Team Dispatch

March 2020 News Roundup

March 12, 2020

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

Michael O'Riordan

May 8, 2019

NewsConference NewsACC 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

March 26, 2019

Top News in Prevention: 2018

Michael O'Riordan

December 28, 2018

NewsOpinionEditor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2018

November 30, 2018

NewsConference NewsAHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

November 5, 2018

Advertisement

Advertisement

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.